February 23, 2022
Market Analyst Marissa Wright Discusses the Psychedelics Market with a Focus on Alcohol Use Disorder
Learn MoreFebruary 3, 2022
Clearmind is proud to host Dr. Gabor Maté to discuss Alcoholism, Trauma, and Clearmind’s candidate treatments
Learn MoreJanuary 26, 2022
Clearmind’s Management Team Explained the Process Required by the FDA to Approve Clearmind’s MEAI as Medicine
Learn More